|
Originally published In Press as doi:10.1194/jlr.M300247-JLR200 on August 1, 2003
Journal of Lipid Research, Vol. 44, 2142-2151, November 2003
Copyright © 2003 by American Society for Biochemistry and Molecular Biology
Dynamics of membrane lipid domains in neuronal cells differentiated in culture1
Elena Ottico,
Alessandro Prinetti2,
Simona Prioni,
Claudia Giannotta,
Luisa Basso,
Vanna Chigorno and
Sandro Sonnino
Department of Medical Chemistry, Biochemistry, and Biotechnology, Center of Excellence on Neurodegenerative Diseases, University of Milan, Segrate, Italy
2 To whom correspondence should be addressed. e-mail: alessandro.prinetti{at}unimi.it
Treatment with methyl-ß-cyclodextrin (MCD) induced a time- and dose-dependent efflux of cholesterol, sphingolipids, and phosphatidylcholine (PC) from cerebellar neurons differentiated in culture. With a "mild" treatment, the loss of cell lipids induced a deep reorganization of the remaining membrane lipids. In fact, the amount of PC associated with a Triton X-100-insoluble membrane fraction (highly enriched in sphingolipids and cholesterol in nontreated cells) was lowered by the treatment. This suggested a reduction of the lipid domain area. However, the cholesterol and sphingolipid enrichment of this fraction remained substantially unchanged, suggesting the existence of dynamic processes aimed at preserving the segregation of cholesterol and sphingolipids in membrane domains. Under these conditions, the lipid membrane domains retained the ability to sort signaling proteins, such as Lyn and c-Src, but cells displayed deep alterations in their membrane permeability. However, normal membrane permeability was restored by loading cells with cholesterol. When MCD treatment was more stringent, a large loss of cell lipids occurred, and the lipid domains were much less enriched in cholesterol and lost the ability to sort specific proteins.
The loss of the integrity and properties of lipid domains was accompanied by severe changes in the membrane permeability, distress, and eventually cell death.
Abbreviations: BME, basal modified Eagle's medium; HPTLC, high-performance thin-layer chromatography; [1-3H]sphingosine, (2S,3R,4E)-2-amino-1,3-dihydroxy-[1-3H]octadecene; MCD, methyl-ß-cyclodextrin; MTT, 3-(4,5-dimethyl-2-thiazoyl)-2,5-diphenyltetrazolium bromide; PC, phosphatidylcholine; SM, sphingomyelin Supplementary key words cholesterol sphingomyelin ganglioside sphingolipid-enriched membrane domain cyclodextrin

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H.-T. Cheng, Megha, and E. London
Preparation and Properties of Asymmetric Vesicles That Mimic Cell Membranes: EFFECT UPON LIPID RAFT FORMATION AND TRANSMEMBRANE HELIX ORIENTATION
J. Biol. Chem.,
March 6, 2009;
284(10):
6079 - 6092.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Thammacharoen, T. A. Lutz, N. Geary, and L. Asarian
Hindbrain Administration of Estradiol Inhibits Feeding and Activates Estrogen Receptor-{alpha}-Expressing Cells in the Nucleus Tractus Solitarius of Ovariectomized Rats
Endocrinology,
April 1, 2008;
149(4):
1609 - 1617.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Tikku, Y. Epshtein, H. Collins, A. J. Travis, G. H. Rothblat, and I. Levitan
Relationship between Kir2.1/Kir2.3 activity and their distributions between cholesterol-rich and cholesterol-poor membrane domains
Am J Physiol Cell Physiol,
July 1, 2007;
293(1):
C440 - C450.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Escartin, E. Brouillet, P. Gubellini, Y. Trioulier, C. Jacquard, C. Smadja, G. W. Knott, L. K.-L. Goff, N. Deglon, P. Hantraye, et al.
Ciliary neurotrophic factor activates astrocytes, redistributes their glutamate transporters GLAST and GLT-1 to raft microdomains, and improves glutamate handling in vivo.
J. Neurosci.,
May 31, 2006;
26(22):
5978 - 5989.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Riff, J. W. Callahan, and P. M. Sherman
Cholesterol-Enriched Membrane Microdomains Are Required for Inducing Host Cell Cytoskeleton Rearrangements in Response to Attaching-Effacing Escherichia coli
Infect. Immun.,
November 1, 2005;
73(11):
7113 - 7125.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Sandhoff, R. Geyer, R. Jennemann, C. Paret, E. Kiss, T. Yamashita, K. Gorgas, T. P. Sijmonsma, M. Iwamori, C. Finaz, et al.
Novel Class of Glycosphingolipids Involved in Male Fertility
J. Biol. Chem.,
July 22, 2005;
280(29):
27310 - 27318.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Hinkovska-Galcheva, L. A. Boxer, A. Kindzelskii, M. Hiraoka, A. Abe, S. Goparju, S. Spiegel, H. R. Petty, and J. A. Shayman
Ceramide 1-Phosphate, a Mediator of Phagocytosis
J. Biol. Chem.,
July 15, 2005;
280(28):
26612 - 26621.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Monnaert, S. Tilloy, H. Bricout, L. Fenart, R. Cecchelli, and E. Monflier
Behavior of {alpha}-, {beta}-, and {gamma}-Cyclodextrins and Their Derivatives on an in Vitro Model of Blood-Brain Barrier
J. Pharmacol. Exp. Ther.,
August 1, 2004;
310(2):
745 - 751.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|